CompletedPhase 3

Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis

South Korea137 participantsStarted 2011-05

Plain-language summary

The purpose of this study is to evaluate efficacy and safety of Cossac L tablet in the treatment of vasomotor rhinitis

Who can participate

Age range12 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of vasomotor rhinitis Exclusion Criteria: * Significant concomitant medical condition * Use corticosteroids or other allergy medications during the study * Considered by investigator as not appropriate to participate in the clinical study with othe reason

What they're measuring

TVRSS(Total Vasomotor Rhinitis Symptom Score)

Timeframe: 2week

Trial details

NCT IDNCT01509209

SponsorHanmi Pharmaceutical Company Limited

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-04

View on ClinicalTrials.gov More Vasomotor Rhinitis trials